The adjuvant treatment of esophageal cancer Journal Article


Author: Minsky, B. D.
Article Title: The adjuvant treatment of esophageal cancer
Abstract: Adjuvant radiation therapy for esophageal cancer can be delivered preoperatively and/or postoperatively. Although one series reports a significant decrease in local/regional failure and two report a survival advantage, when the data are combined, there is no clear advantage for preoperative radiation therapy. One of the two trials of postoperative radiation therapy used conventional radiation doses and did report a significant decrease in local/regional failure. However, this improvement was seen only in node-negative patients. Overall, there is limited benefit to adjuvant radiation therapy in the treatment of esophageal cancer. The more innovative approach of radiation therapy plus chemotherapy, either in the adjuvant setting or as a primary treatment modality, holds greater promise. © 1994 W.B. Saunders Company. All rights reserved.
Keywords: cancer survival; cisplatin; fluorouracil; cancer combination chemotherapy; cancer radiotherapy; radiation dose; radiation injury; esophagus cancer; complication; human; priority journal; article
Journal Title: Seminars in Radiation Oncology
Volume: 4
Issue: 3
ISSN: 1053-4296
Publisher: Elsevier Inc.  
Date Published: 1994-07-01
Start Page: 165
End Page: 169
Language: English
DOI: 10.1016/s1053-4296(05)80064-5
PROVIDER: scopus
PUBMED: 10717104
DOI/URL:
Notes: Semin. Radiat. Oncol. -- Cited By :6 -- Export Date: 14 January 2019 -- Article -- CODEN: SRONE -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Bruce Minsky
    306 Minsky